These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1415600

  • 1. Differential effects of WEB 2086 and SRI 63-441 on TNF-alpha-induced alterations in cardiopulmonary function.
    Kruse-Elliott KT, Dodam JR, Johnson LW, Olson NC.
    Am J Physiol; 1992 Sep; 263(3 Pt 2):H761-70. PubMed ID: 1415600
    [Abstract] [Full Text] [Related]

  • 2. Effect of PAF receptor antagonism on cardiopulmonary alterations during coinfusion of TNF-alpha and IL-1 alpha in pigs.
    Kruse-Elliott KT, Pino MV, Olson NC.
    Am J Physiol; 1993 Feb; 264(2 Pt 1):L175-82. PubMed ID: 8383447
    [Abstract] [Full Text] [Related]

  • 3. Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo.
    Kruse-Elliott KT, Whorton AR, Olson NC.
    Shock; 1998 Jan; 9(1):40-5. PubMed ID: 9466472
    [Abstract] [Full Text] [Related]

  • 4. Effect of 5-lipoxygenase and cyclooxygenase blockade on porcine hemodynamics during continuous infusion of platelet-activating factor.
    Olson NC, Kruse-Elliott KT, Johnson LW.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):549-59. PubMed ID: 8415804
    [Abstract] [Full Text] [Related]

  • 5. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW.
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [Abstract] [Full Text] [Related]

  • 6. CGS 8515 and indomethacin attenuate cytokine-induced cardiopulmonary dysfunction in pigs.
    Kruse-Elliott KT, Olson NC.
    Am J Physiol; 1993 Apr; 264(4 Pt 2):H1076-86. PubMed ID: 8386479
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary vascular reactivity: effect of PAF and PAF antagonists.
    Chen CR, Voelkel NF, Chang SW.
    J Appl Physiol (1985); 1992 Nov; 73(5):1762-9. PubMed ID: 1474049
    [Abstract] [Full Text] [Related]

  • 8. Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
    Christman BW, Lefferts PL, Blair IA, Snapper JR.
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1272-8. PubMed ID: 2174655
    [Abstract] [Full Text] [Related]

  • 9. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs.
    Olson NC, Joyce PB, Fleisher LN.
    Am J Physiol; 1990 Jun; 258(6 Pt 2):H1674-86. PubMed ID: 2163217
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086.
    Wilson DV, Eberhart SW, Robinson NE, Rice R, Gray PR.
    Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938
    [Abstract] [Full Text] [Related]

  • 11. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
    Alloatti G, Penna C, De Martino A, Montrucchio G, Camussi G.
    Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
    [Abstract] [Full Text] [Related]

  • 12. Role of platelet-activating factor in mediating tumor necrosis factor alpha-induced pulmonary vasoconstriction and plasma-lymph protein transport.
    Horvath CJ, Kaplan JE, Malik AB.
    Am Rev Respir Dis; 1991 Dec; 144(6):1337-41. PubMed ID: 1741548
    [Abstract] [Full Text] [Related]

  • 13. Effects of platelet-activating factor antagonist SRI 63-441 on endotoxemia in sheep.
    Sessler CN, Glauser FL, Davis D, Fowler AA.
    J Appl Physiol (1985); 1988 Dec; 65(6):2624-31. PubMed ID: 3145934
    [Abstract] [Full Text] [Related]

  • 14. Sustained effects of platelet-activating factor infusion in piglets.
    Stambouly JJ, Bradley LM, Czaja JF, Goldstein RE.
    Pediatr Res; 1991 Sep; 30(3):261-5. PubMed ID: 1945566
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-induced lung injury is not mediated by platelet-activating factor.
    Chang SW, Ohara N, Kuo G, Voelkel NF.
    Am J Physiol; 1989 Oct; 257(4 Pt 1):L232-9. PubMed ID: 2801951
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV, Slotman GJ.
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [Abstract] [Full Text] [Related]

  • 17. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    Rabinovici R, Yue TL, Farhat M, Smith EF, Esser KM, Slivjak M, Feuerstein G.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):256-63. PubMed ID: 2213560
    [Abstract] [Full Text] [Related]

  • 18. Platelet-activating factor: evidence against a role in hypoxic pulmonary vasoconstriction.
    McCormack DG, Barnes PJ, Evans TW.
    Crit Care Med; 1990 Dec; 18(12):1398-402. PubMed ID: 2245615
    [Abstract] [Full Text] [Related]

  • 19. Lipid mediators of tumor necrosis factor-alpha-induced uveitis.
    Fleisher LN, Ferrell JB, Smith MG, McGahan MC.
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2393-9. PubMed ID: 1649146
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
    Håkansson L, Venge P.
    J Leukoc Biol; 1990 May; 47(5):449-56. PubMed ID: 2335754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.